Challenging the “Lethal” Label in LCCS11 : A Report on Three Patients With GLDN Variants
American Journal of Medical Genetics Part C: Seminars in Medical Genetics · 18.11.2026
DOI: 10.1002/ajmg.c.70054 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Medical Genetics Part C: Seminars in Medical Genetics, online erschienen am 18.11.2026. Verfasst von Anna Kuźnik‐Buziewicz und 3 weiteren Autor:innen. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
GLDN encodes gliomedin, required for the formation and long‐term maintenance of Na + channels at the nodes of Ranvier. Biallelic variants in GLDN , associated with lethal congenital contracture syndrome 11 (LCCS11), may prevent the formation of functional nodes, causing a peripheral neuropathy leading to arthrogryposis and respiratory insufficiency. This clinical phenotype falls within the spectrum of anomalies included under the umbrella term fetal akinesia deformation sequence (FADS) and is often associated with perinatal lethality. However, survival beyond the neonatal period has been documented. Moreover, significant advances in the respiratory care of infants—based on experience from preterm infants and those with congenital diaphragmatic hernia—along with improvements in neonatal intensive care, appear to be increasing survival rates for these patients. In this report, we describe three patients with biallelic variants in GLDN from two unrelated families, two of whom have survived infancy. We also highlight the importance of recognizing fetal akinesia in utero, pursuing further investigation when identified, and planning delivery in appropriate neonatal care settings. Additionally, we address potential bias in treatment decisions arising from the term “lethal” in LCCS11.
Zitieren
APA
Kuźnik‐Buziewicz, A., Kowalczyk, B., Fąfara, A., & Dobosz, A. (2026). Challenging the “Lethal” Label in LCCS11 : A Report on Three Patients With GLDN Variants. American Journal of Medical Genetics Part C: Seminars in Medical Genetics. https://doi.org/10.1002/ajmg.c.70054
Vancouver
Kuźnik‐Buziewicz A, Kowalczyk B, Fąfara A, Dobosz A. Challenging the “Lethal” Label in LCCS11 : A Report on Three Patients With GLDN Variants. American Journal of Medical Genetics Part C: Seminars in Medical Genetics. 2026. doi:10.1002/ajmg.c.70054
BibTeX
@article{KunikBuziewicz2026,
author = {Kuźnik‐Buziewicz, Anna and Kowalczyk, Bartłomiej and Fąfara, Alicja and Dobosz, Artur},
title = {Challenging the “Lethal” Label in LCCS11 : A Report on Three Patients With GLDN Variants},
journal = {American Journal of Medical Genetics Part C: Seminars in Medical Genetics},
year = {2026},
doi = {10.1002/ajmg.c.70054}
}
EUVIMED